Scalable production of adeno-associated virus type 2 vectors via suspension transfection
- PMID: 16622883
- DOI: 10.1002/bit.20776
Scalable production of adeno-associated virus type 2 vectors via suspension transfection
Abstract
Vectors derived from adeno-associated virus type 2 (AAV2) are promising gene delivery vehicles, but it is still challenging to get the large number of recombinant adeno-associated virus (rAAV) particles required for large animal and clinical studies. Current transfection technology requires adherent cultures of HEK 293 cells that can only be expanded by preparing multiple culture plates. A single large-scale suspension culture could replace these multiple culture preparations, but there is currently no effective co-transfection scheme for generating rAAV from cells in suspension culture. Here, we weaned HEK 293 cells to suspension culture using hydrogel-coated six-well culture plates and established an efficient transfection strategy suitable for these cells. Then the cultures were gradually scaled up. We used linear polyethylenimine (PEI) to mediate transfection and obtained high transfection efficiencies ranging from 54% to 99%, thereby allowing efficient generation of rAAV vectors. Up to 10(13) rAAV particles and, more importantly, up to 10(11) infectious particles were generated from a 2-L bioreactor culture. The suspension-transfection strategy of this study facilitates the homogeneous preparation of rAAV at a large scale, and holds further potential as the basis for establishing a manufacturing process in a larger bioreactor.
2006 Wiley Periodicals, Inc.
Similar articles
-
Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.J Virol Methods. 2007 Sep;144(1-2):32-40. doi: 10.1016/j.jviromet.2007.03.014. Epub 2007 Apr 30. J Virol Methods. 2007. PMID: 17467815
-
Improvement in the suspension-culture production of recombinant adeno-associated virus-LacZ in HEK-293 cells using polyethyleneimine-DNA complexes in combination with hypothermic treatment.Biotechnol Appl Biochem. 2008 Jun;50(Pt 2):121-32. doi: 10.1042/BA20070081. Biotechnol Appl Biochem. 2008. PMID: 17880281
-
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.Gene Ther. 1999 Jun;6(6):986-93. doi: 10.1038/sj.gt.3300937. Gene Ther. 1999. PMID: 10455400
-
Clinical gene therapy using recombinant adeno-associated virus vectors.Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Epub 2008 Apr 17. Gene Ther. 2008. PMID: 18418415 Review.
-
Development and optimization of an adenovirus production process.J Gene Med. 2004 Feb;6 Suppl 1:S184-92. doi: 10.1002/jgm.503. J Gene Med. 2004. PMID: 14978761 Review.
Cited by
-
Gene Therapy of Salivary Diseases.Methods Mol Biol. 2017;1537:107-123. doi: 10.1007/978-1-4939-6685-1_6. Methods Mol Biol. 2017. PMID: 27924590 Free PMC article.
-
Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T Cells.Hum Gene Ther. 2023 Aug;34(15-16):697-704. doi: 10.1089/hum.2023.032. Hum Gene Ther. 2023. PMID: 37171121 Free PMC article.
-
AAV genome modification for efficient AAV production.Heliyon. 2023 Apr 1;9(4):e15071. doi: 10.1016/j.heliyon.2023.e15071. eCollection 2023 Apr. Heliyon. 2023. PMID: 37095911 Free PMC article. Review.
-
Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.J Virol Methods. 2014 Feb;196:163-73. doi: 10.1016/j.jviromet.2013.10.038. Epub 2013 Nov 13. J Virol Methods. 2014. PMID: 24239634 Free PMC article.
-
Transient transfection methods for clinical adeno-associated viral vector production.Hum Gene Ther. 2009 Jul;20(7):698-706. doi: 10.1089/hum.2009.064. Hum Gene Ther. 2009. PMID: 19438300 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous